Clinical manifestations and management of the antiphospholipid syndrome

Lupus

Volumn 5, Issue 2, 1996, Pages 167-169

  Derksen, R H W M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Anticardiolipin antibodies; Antiphospholipid syndrome; Lupus anticoagulant

Indexed keywords

ANTICOAGULANT AGENT; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; CONFERENCE PAPER; FETUS WASTAGE; HUMAN; LIVEDO RETICULARIS; ORAL DRUG ADMINISTRATION; PATIENT CARE; PATIENT COUNSELING; PLASMAPHERESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0030001791     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500217     Document Type: Conference Paper

References (18)

1. Harris EN, Gharavi AE, Hughes GRV. Anti-phospholipid antibodies. Clin Rheum Dis 1985; 11: 591-609.
2. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 49: 193-280.
3. Triplett DA, Brandt J. Laboratory identification of the lupus anticoagulant. Br J Haematol 1989; 73: 139-142
4. Triplett DA. Antiphospholipid antibodies and thrombosis. Arch Pathol Lab Med 1993; 117: 78-88.
5. Vermylen J, Arnout J. Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid-protein complexes? J Lab Clin Med 1992; 120: 10-12.
6. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins •a new view of lupus anticoagulants and other 'antiphospholipid' autoantibodies. Blood 1994; 84; 2854-2867.
7. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990; 112: 682-698.
8. Piette JP et al Exclusion criteria for primary antiphospholipid syndrome. J Rheumatol 1993; 20: 1802-1803.
9. Derksen RHWM, Gmelig-Meijling FHJ, de Groot PhG. Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. Lupus 1995; in press.
10. Alarcon-Segovia D et al. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Sem Arthritis Rheum 1992; 21: 275-286.
11. Asherson RA, Cervera R. Anticardiolipin antibodies, chronic false-positive tests for syphilis and other antiphospholipid antibodies. In: Wallace DH, Hahn BH (eds). Dubois' lupus erythematosus. Philadelphia. Lea & Febiger, 1993; 233-245.
12. Cervera R, Asherson RA, Lie JT Clinicopathologic correlations of the antiphospholipid syndrome. Sem Arthritis Rheum 1995; 24: 262-272.
13. Weinstein C, Miller MH, Buchanan R, Littlejohn GO. Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus. Arch Dermatol 1987; 123: 596-600.
14. Piette JC, Cacoub P, Wechsler B. Renal manifestations of the antiphospholipid syndrome Sem Arthritis Rheum 1994; 23: 357-366.
15. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 1992; 19: 508-512.
16. Rosove MH, Brewer PMC. Antiphospholipid thrombosis. Clinical course after the first thrombotic event in 70 patients. Ann Int Med 1992; 117: 303-308.
17. Derksen RHWM, de Groot PhG, Kater L, Nieuwenhuis HK. Patients with antiphospholipid antibodies and venous thrombosis should receive long-term anticoagulation. Ann Rheum Dis 1993; 52: 689-692.
18. Khamashta MA et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 993-997.